Cargando…

Efficacy of sunscreen with photolyase or regular sunscreen associated with topical antioxidants in treating advanced photodamage and cutaneous field cancerization: a randomized clinical trial()()

BACKGROUND: Several treatments are available for skin with advanced photodamage, which is characterized by the presence of actinic keratoses (AK). OBJECTIVES: Evaluate the efficacy of using sunscreen with photolyase compared to regular sunscreen, as well as to compare the combination of a topical fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Alvares, Bruno Augusto, Miola, Anna Carolina, Schimitt, Juliano Vilaverde, Miot, Helio Amante, Abbade, Luciana Patricia Fernandes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Dermatologia 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073224/
https://www.ncbi.nlm.nih.gov/pubmed/35039206
http://dx.doi.org/10.1016/j.abd.2021.06.005
_version_ 1784701237993668608
author Alvares, Bruno Augusto
Miola, Anna Carolina
Schimitt, Juliano Vilaverde
Miot, Helio Amante
Abbade, Luciana Patricia Fernandes
author_facet Alvares, Bruno Augusto
Miola, Anna Carolina
Schimitt, Juliano Vilaverde
Miot, Helio Amante
Abbade, Luciana Patricia Fernandes
author_sort Alvares, Bruno Augusto
collection PubMed
description BACKGROUND: Several treatments are available for skin with advanced photodamage, which is characterized by the presence of actinic keratoses (AK). OBJECTIVES: Evaluate the efficacy of using sunscreen with photolyase compared to regular sunscreen, as well as to compare the combination of a topical formulation of antioxidants versus placebo in the treatment of advanced photodamage. METHODS: This was a randomized, double-blind, factorial clinical trial. Participants with AKs on their forearms were randomized to apply regular sunscreen (SC) or sunscreen with photolyase (SC+P) on both forearms during the day. One of the forearms in each group was randomized again to receive topical antioxidants (AOx), and the other forearm received a placebo cream (both for night application). The four groups were SC/AOx, SC/placebo, SC+P/AOx, and SC+P/placebo. The duration of treatment was 8 weeks. Primary outcomes were total AK clearance, decrease in Forearm Photoaging Scale (FPS), and AK severity scores. Secondary outcomes were reduction in AK count, partial clearance rate, and safety. RESULTS: Forty participants (80 forearms) were included. All groups showed significant improvement in outcomes at week eight. There were no significant differences between SC and SC+P for either outcome. AOx led to a significant reduction in AK count (22%; p < 0.05). Partial clearance was obtained in 18 (47.4%) forearms treated with AOx and in 9 (23.7%) treated with placebo (p < 0.05). All groups reduced the FPS score, without significant differences among them. CONCLUSIONS: There is no difference in the treatment of advanced photodamage skin when comparing the use of sunscreen with photolyase and regular sunscreen, and topical antioxidants were more efficient in reducing AK count than placebo. STUDY LIMITATIONS: Short interval of follow-up and absence of re-evaluation in the absence of treatment were limitations of the present study.
format Online
Article
Text
id pubmed-9073224
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Sociedade Brasileira de Dermatologia
record_format MEDLINE/PubMed
spelling pubmed-90732242022-05-13 Efficacy of sunscreen with photolyase or regular sunscreen associated with topical antioxidants in treating advanced photodamage and cutaneous field cancerization: a randomized clinical trial()() Alvares, Bruno Augusto Miola, Anna Carolina Schimitt, Juliano Vilaverde Miot, Helio Amante Abbade, Luciana Patricia Fernandes An Bras Dermatol Original Article BACKGROUND: Several treatments are available for skin with advanced photodamage, which is characterized by the presence of actinic keratoses (AK). OBJECTIVES: Evaluate the efficacy of using sunscreen with photolyase compared to regular sunscreen, as well as to compare the combination of a topical formulation of antioxidants versus placebo in the treatment of advanced photodamage. METHODS: This was a randomized, double-blind, factorial clinical trial. Participants with AKs on their forearms were randomized to apply regular sunscreen (SC) or sunscreen with photolyase (SC+P) on both forearms during the day. One of the forearms in each group was randomized again to receive topical antioxidants (AOx), and the other forearm received a placebo cream (both for night application). The four groups were SC/AOx, SC/placebo, SC+P/AOx, and SC+P/placebo. The duration of treatment was 8 weeks. Primary outcomes were total AK clearance, decrease in Forearm Photoaging Scale (FPS), and AK severity scores. Secondary outcomes were reduction in AK count, partial clearance rate, and safety. RESULTS: Forty participants (80 forearms) were included. All groups showed significant improvement in outcomes at week eight. There were no significant differences between SC and SC+P for either outcome. AOx led to a significant reduction in AK count (22%; p < 0.05). Partial clearance was obtained in 18 (47.4%) forearms treated with AOx and in 9 (23.7%) treated with placebo (p < 0.05). All groups reduced the FPS score, without significant differences among them. CONCLUSIONS: There is no difference in the treatment of advanced photodamage skin when comparing the use of sunscreen with photolyase and regular sunscreen, and topical antioxidants were more efficient in reducing AK count than placebo. STUDY LIMITATIONS: Short interval of follow-up and absence of re-evaluation in the absence of treatment were limitations of the present study. Sociedade Brasileira de Dermatologia 2022 2022-01-14 /pmc/articles/PMC9073224/ /pubmed/35039206 http://dx.doi.org/10.1016/j.abd.2021.06.005 Text en © 2021 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Original Article
Alvares, Bruno Augusto
Miola, Anna Carolina
Schimitt, Juliano Vilaverde
Miot, Helio Amante
Abbade, Luciana Patricia Fernandes
Efficacy of sunscreen with photolyase or regular sunscreen associated with topical antioxidants in treating advanced photodamage and cutaneous field cancerization: a randomized clinical trial()()
title Efficacy of sunscreen with photolyase or regular sunscreen associated with topical antioxidants in treating advanced photodamage and cutaneous field cancerization: a randomized clinical trial()()
title_full Efficacy of sunscreen with photolyase or regular sunscreen associated with topical antioxidants in treating advanced photodamage and cutaneous field cancerization: a randomized clinical trial()()
title_fullStr Efficacy of sunscreen with photolyase or regular sunscreen associated with topical antioxidants in treating advanced photodamage and cutaneous field cancerization: a randomized clinical trial()()
title_full_unstemmed Efficacy of sunscreen with photolyase or regular sunscreen associated with topical antioxidants in treating advanced photodamage and cutaneous field cancerization: a randomized clinical trial()()
title_short Efficacy of sunscreen with photolyase or regular sunscreen associated with topical antioxidants in treating advanced photodamage and cutaneous field cancerization: a randomized clinical trial()()
title_sort efficacy of sunscreen with photolyase or regular sunscreen associated with topical antioxidants in treating advanced photodamage and cutaneous field cancerization: a randomized clinical trial()()
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073224/
https://www.ncbi.nlm.nih.gov/pubmed/35039206
http://dx.doi.org/10.1016/j.abd.2021.06.005
work_keys_str_mv AT alvaresbrunoaugusto efficacyofsunscreenwithphotolyaseorregularsunscreenassociatedwithtopicalantioxidantsintreatingadvancedphotodamageandcutaneousfieldcancerizationarandomizedclinicaltrial
AT miolaannacarolina efficacyofsunscreenwithphotolyaseorregularsunscreenassociatedwithtopicalantioxidantsintreatingadvancedphotodamageandcutaneousfieldcancerizationarandomizedclinicaltrial
AT schimittjulianovilaverde efficacyofsunscreenwithphotolyaseorregularsunscreenassociatedwithtopicalantioxidantsintreatingadvancedphotodamageandcutaneousfieldcancerizationarandomizedclinicaltrial
AT miothelioamante efficacyofsunscreenwithphotolyaseorregularsunscreenassociatedwithtopicalantioxidantsintreatingadvancedphotodamageandcutaneousfieldcancerizationarandomizedclinicaltrial
AT abbadelucianapatriciafernandes efficacyofsunscreenwithphotolyaseorregularsunscreenassociatedwithtopicalantioxidantsintreatingadvancedphotodamageandcutaneousfieldcancerizationarandomizedclinicaltrial